Revival Research Institute, LLC.

Southfield, Michigan 48075

2 studies enrolling now · 7 studies all time

What they study most

Alopecia Areata, Alzheimer Disease, Atopic Dermatitis, Atopic Dermatitis Eczema, Atopic Dermatitis of Scalp, COVID-19, Clostridioides Difficile Infection, Crohn's Disease, Dementia, Hidradenitis Suppurativa, Plaque, Amyloid, SARS-COV-2 Infection

Studies at this site

• A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. — Recruiting now
• A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT). — Recruiting now
• Phase 2 Trial of HY209gel in Atopic Dermatitis Patients — Completed
• A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata — Running, not enrolling
• A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age — Running, not enrolling
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection — Completed
• Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease — Stopped early